Clinical Implications of Coexisting EWSR1 Rearrangements in Ewing Sarcoma: A Database Analysis and Representative...

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Ewing sarcoma (ES) is an aggressive cancer with poor prognosis, especially in metastatic stages.
• The EWSR1-FLI1 fusion gene is the primary molecular hallmark of ES.
• Localized ES shows better survival rates than metastatic disease at presentation.

Purpose of the Study:

• To investigate the impact of additional EWSR1 rearrangements on treatment outcomes in ES.
• To analyze a national cancer genomic database for these molecular alterations.
• To understand prognostic implications for treatment resistance.

Main Methods:

• Exploratory retrospective analysis of genomic data and treatment response.
• Utilized the Center for Cancer Genomics and Advanced Therapeutics (C-CAT) database.
• Focused on bone and soft tissue tumors diagnosed as ES (n=90).

Main Results:

• A subset of ES cases exhibited additional EWSR1 rearrangements beyond the primary fusion.
• Cases with coexisting rearrangements showed higher disease progression rates with first-line chemotherapy.
• Institutional data showed isolated EWSR1-FLI1 fusion responded well, while additional ETS1-EWSR1 rearrangement indicated primary resistance.

Conclusions:

• Coexisting EWSR1 rearrangements may serve as important prognostic markers in ES.
• Further research is needed to optimize treatment strategies for ES with these complex rearrangements.
• Understanding these genetic alterations is crucial for managing treatment-resistant ES.